DOCS
Doximity, Inc. · Healthcare · Medical - Healthcare Information Services
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | -8 | 101.96M | $2.11B | +7 | −14 |
| Q1 2026 | 124 | -12 | 93.12M | $2.18B | +2 | −15 |
| Q4 2025 | 137 | +3 | 98.50M | $4.36B | +5 | −1 |
| Q3 2025 | 20 | -1 | 62.52M | $4.57B | — | −2 |
| Q2 2025 | 19 | 0 | 60.43M | $3.71B | +1 | −1 |
| Q1 2025 | 16 | -1 | 22.41M | $1.30B | +1 | −2 |
| Q4 2024 | 17 | +2 | 19.67M | $1.05B | +2 | — |
| Q3 2024 | 14 | +1 | 14.27M | $621.81M | +2 | −1 |
| Q2 2024 | 13 | — | 13.99M | $391.40M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 5.90M | — | $164.93M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 5.90M | — | $164.93M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 5.90M | — | $164.93M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 5.90M | — | $164.93M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 2.38M | — | $66.71M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasif) | 2.38M | — | $66.71M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Capital World Investors ✦ | 1.71M | — | $47.96M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 1.60M | — | $44.84M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (pasif) | 1.14M | — | $31.81M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 503.74K | — | $14.09M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 503.74K | — | $14.09M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 221.35K | — | $6.19M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 164.18K | — | $4.59M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 162.30K | — | $4.54M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 162.30K | — | $4.54M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 86.30K | — | $2.41M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 45.85K | — | $1.28M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 45.85K | — | $1.28M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 41.72K | — | $1.17M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 31.34K | — | $870,340 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 31.34K | — | $870,340 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 418 pemegang, 119.59M saham, $2.71B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 1.77K lbr · $44,144
Director · 7.50K lbr · $293,325
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi